Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein
Clinical trial NCT05922852 · UNKNOWN
Trial details
- NCT number
- NCT05922852
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-02-28
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.